Lymphoma / Leukemia / Myeloma photo

Lymphoma / Leukemia / Myeloma News

The latest Lymphoma News & Leukemia News & Myeloma News articles published daily. Includes news on hematological malignancies (blood and lymphatic cancers), Hodgkin's Disease, Epstein-Barr Virus and more.

Add this Lymphoma rss news feed to your rss reader:  View Our Lymphoma / Leukemia / Myeloma XML Feed

Lymphoma / Leukemia / Myeloma News Articles Archive  -   Page 13

05 December 2010

Zoledronic Acid Shows Anticancer Activity In Multiple Myeloma Patients, As Well As Protecting Bone Health
Mitoxantrone Is Significantly Better Than Idarubicin At Improving The Outcome Of Children With Relapsed Acute Lymphoblastic Leukaemia
A New Tool To Predict Complete Remission Or Early Death In Patients With Acute Myeloid Leukaemia
04 December 2010

Phase III Data Published In Lancet Show Novartis Drug Zometa® Improves Overall Survival In Newly Diagnosed Multiple Myeloma Patients
Cell Therapeutics Files Appeal On FDA Decision On New Drug Application (NDA) For Pixantrone To Treat Aggressive Non-Hodgkin's Lymphoma
US Oncology Research Investigators Participated In Studies That Will Be Presented At The 2010 American Society Of Hematology Annual Meeting
Pfizer Plans Regulatory Submissions Of Bosutinib In Chronic Myeloid Leukemia
03 December 2010

Keryx Biopharmaceuticals Announces Poster Presentations Of KRX-0401 (Perifosine) At The 52nd Annual Meeting Of The American Society Of Hematology
MorphoSys And Xencor Initiate Phase 1 Study Of Anti-CD19 Antibody In Chronic Lymphocytic Leukemia
02 December 2010

Signal Genetics Announces Launch Of Revolutionary Molecular Test For Multiple Myeloma Patients
Data At ASH, SABCS Demonstrate Commitment Of Novartis R&D In Advancing Treatments For Patients With Cancer And Rare Diseases
Stemline Therapeutics, Inc. Announces Presentations Of SL-401 Clinical And Pre-Clinical Efficacy
01 December 2010

Researchers To Present 12 Oral And 28 Poster Sessions At The Premier Hematology Research Conference
30 November 2010

Pfizer To Present Data From Its Hematology Portfolio At The 52nd Annual Meeting Of The American Society Of Hematology
Tiny RNA Shown To Cause Multiple Types Of Leukemia
25 November 2010

Long-Term Survival Of Blood Cancers Improved By A Decade Of Refinements In Transplantation
23 November 2010

Fourth Compound From S*BIO, Oral Multi-Kinase Inhibitor SB1317, Enters Phase 1 Clinical Trial In Advanced/Refractory Hematologic Malignancies
22 November 2010

JAK3 Pathway Highlighted As Leukemia Target
19 November 2010

FDA Approves Amgen's XGEVA(TM) (Denosumab) For The Prevention Of Skeletal-Related Events In Patients With Bone Metastases From Solid Tumors
The European Medicines Agency Validates And Accepts Cell Therapeutics' Marketing Authorization Application For Pixuvri™
Fda Approves Amgen's Xgeva™ (Denosumab) For The Prevention Of Skeletal-Related Events In Patients With Bone Metastases From Solid Tumors
$16.5 Million For UC Berkeley For Three Children's Environmental Health Centers
16 November 2010

Novel Opportunity For Treatment Of Genetically Defined Human B-Cell Lymphomas
Deaths From Cancer In Children Fall By Almost 60 Per Cent Since The '60s, UK
14 November 2010

Arsenic Early In Treatment Improves Survival For Leukemia Patients
12 November 2010

Arsenic Early In Treatment Improves Survival For Leukemia Patients
Key Mutation Discovered In Acute Myeloid Leukemia
Mutations In Single Gene Predict Poor Outcomes In Adult Leukemia
11 November 2010

Viertel Foundation Fellowship For Leading Cancer Researcher
10 November 2010

EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) For Treatment Of Acute Lymphoblastic Leukemia
EntreMed ENMD-2076 Phase 1 Data In Hematological Studies To Be Presented At ASH
09 November 2010

Patients Can Be Monitored For Lymphoma Based On New Risk Factor
07 November 2010

NICE Consults Again On The Use Of Azacitidine To Treat Myelodysplastic Syndromes
05 November 2010

Experimental Drug For Hodgkin's Lymphoma Shows Promise
04 November 2010

Armed Antibody Triggers Remissions For Hodgkin Lymphoma
New Lymphoma Therapy May Be More Effective With Fewer Side Effects
03 November 2010

A Discovery Could Be Important For The Therapy Of Lymphoma And Leukemia
New Mutation Linked To Non-Hodgkin's Lymphoma
02 November 2010

Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application For Pixuvri(R)
New Potential Drug Combination For Most Common Form Of Non-Hodgkin Lymphoma
JCI Online Early Table Of Contents: Nov. 1, 2010
Oncolytics Biotech(R) Inc. Collaborators To Present Reovirus Research At The EORTC-NCI-AACR Meeting
29 October 2010

FDA Approves Additional Medical Indication For Sprycel
MIT Researchers Discover That Tumor Cells Can Escape From Chemotherapy
28 October 2010

Study Identifies Key Molecules In Multiple Myeloma
27 October 2010

Celator® Pharmaceuticals Completes Enrollment In A Second Phase 2 Trial Of CPX-351 In Acute Myeloid Leukemia
26 October 2010

Newer, More Intense Chemotherapy With Less Radiation Not More Effective Against Hodgkin's Lymphoma
25 October 2010

Factor Boosting Leukemia's Aggressiveness Identified By UC San Diego Researchers
At ASTRO Annual Meeting: Practice-Changing Studies On How Oncologists Treat Cancer
24 October 2010

SPRYCEL Receives CHMP Positive Opinion For The Treatment Of Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive CML In Chronic Phase
22 October 2010

Genzyme Announces Results Of Phase 3 Trial Of Clolar In Adult AML
21 October 2010

LSUHSC Awarded $12 Million For Cancer, Infectious Diseases Research & Research Pipeline
Reviving 'Tired' Immune Cells Gives Blood Cancer Treatment A Boost
20 October 2010

SHIP Protein Identified As A B Cell Tumor Suppressor
Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation For The Treatment Of Hodgkin Lymphoma By The European Commission
17 October 2010

Scientists Discover Inner Workings Of Potent Cancer Drug
16 October 2010

Powerful Mutation Tool Identifies New Cancer Genes
15 October 2010

Immune Development And Regulation: A Crucial Link Unearthed
14 October 2010

Leading Authority In Cancer Treatment, Research To Chair UF's Department Of Medicine
Links Between XMRV And Human Disease Examined In New Studies
Go To News Page:
[First Page] [Prev] 3 4 5 6 7 8 9 10 11 12 [13] 14 15 16 17 18 19 20 21 22 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



Lymphoma / Leukemia / Myeloma

What Is Lymphoma?

Lymphoma is a type of cancer that begins in immune system cells called lymphocytes. Like other cancers, lymphoma occurs when lymphocytes are in a state of uncontrolled cell growth and multiplication. Read more...

Most Popular Articles



Follow Our Lymphoma News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Lymphoma / Leukemia / Myeloma Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »